Molecular profiling of the Basal-like intrinsic molecular subtype in primary ER-positive HER2-negative breast cancer
Abstract Background The clinical management of ER-positive/HER2-negative (ERpHER2n) breast cancer is complicated by a heterogeneous patient population, with some patients exhibiting endocrine resistance and an increased risk of recurrence. Among these high-risk subgroups, ERpHER2n Basal-like (ERpHER...
Збережено в:
| Автори: | , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2025-12-01
|
| Серія: | Genome Medicine |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1186/s13073-025-01576-9 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|